Conrad‐Amadeus Voltin

543 total citations
23 papers, 271 citations indexed

About

Conrad‐Amadeus Voltin is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Conrad‐Amadeus Voltin has authored 23 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Conrad‐Amadeus Voltin's work include Lymphoma Diagnosis and Treatment (17 papers), Medical Imaging Techniques and Applications (11 papers) and Lung Cancer Treatments and Mutations (11 papers). Conrad‐Amadeus Voltin is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Medical Imaging Techniques and Applications (11 papers) and Lung Cancer Treatments and Mutations (11 papers). Conrad‐Amadeus Voltin collaborates with scholars based in Germany, Switzerland and Netherlands. Conrad‐Amadeus Voltin's co-authors include Carsten Kobe, Peter Borchmann, Markus Dietlein, Jasmin Mettler, Christian Baues, Alexander Drzezga, Andreas Engert, Horst Müller, Georg Kuhnert and Michael Fuchs and has published in prestigious journals such as Blood, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Conrad‐Amadeus Voltin

21 papers receiving 270 citations

Peers

Conrad‐Amadeus Voltin

PFM

RNMI

PRM

ONCOL

NEURO

Jasmin Mettler Germany

Simone Pieplenbosch Netherlands

Ivan Santi Italy

A Goßmann Germany

Özgür Ömür Türkiye

Agnieszka Giza Poland

Lia Palomba United States

D S Goldstein United States

Ihl Bohng Choi South Korea

Youngil Koh South Korea

Jasmin Mettler Germany

Conrad‐Amadeus Voltin

174 ×1.0

PFM

133 ×0.8

RNMI

73 ×0.9

PRM

41 ×0.6

ONCOL

43 ×0.9

NEURO

Citations per year, relative to Conrad‐Amadeus Voltin Conrad‐Amadeus Voltin (= 1×) peers Jasmin Mettler

Countries citing papers authored by Conrad‐Amadeus Voltin

Since Specialization

Citations

This map shows the geographic impact of Conrad‐Amadeus Voltin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad‐Amadeus Voltin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad‐Amadeus Voltin more than expected).

Fields of papers citing papers by Conrad‐Amadeus Voltin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conrad‐Amadeus Voltin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad‐Amadeus Voltin. The network helps show where Conrad‐Amadeus Voltin may publish in the future.

Co-authorship network of co-authors of Conrad‐Amadeus Voltin

This figure shows the co-authorship network connecting the top 25 collaborators of Conrad‐Amadeus Voltin. A scholar is included among the top collaborators of Conrad‐Amadeus Voltin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conrad‐Amadeus Voltin. Conrad‐Amadeus Voltin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kutsch, Nadine, Philipp Gödel, Conrad‐Amadeus Voltin, et al.. (2024). Long‐term remission in a patient with relapsed Richter's transformation treated with CD19‐directed chimeric antigen‐receptor T‐cells after allogeneic stem cell transplantation. European Journal Of Haematology. 112(6). 984–987. 1 indexed citations

Bröckelmann, Paul J., Lydia Visser, Conrad‐Amadeus Voltin, et al.. (2024). Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume during Anti-PD1-Based First-Line HL Treatment in the GHSG Phase II Nivahl Trial. Blood. 144(Supplement 1). 3044–3044. 1 indexed citations

Voltin, Conrad‐Amadeus, et al.. (2023). PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor Volume. Academic Radiology. 31(7). 3020–3025. 4 indexed citations

Müller, Horst, Jasmin Mettler, Christian Baues, et al.. (2023). Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early‐stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial. European Journal Of Haematology. 111(6). 881–887. 6 indexed citations

Wegen, Simone, Conrad‐Amadeus Voltin, Klaus Schomäcker, et al.. (2023). Dual-tracer PET/CT protocol with [18F]FDG and [68Ga]Ga-FAPI-46 outperforms single-tracer PET/CT with [18F]FDG in different cancer types, resulting in larger functional and gross tumor volume. Strahlentherapie und Onkologie. 200(1). 28–38. 8 indexed citations

Mettler, Jasmin, Felicitas Hitz, Christian Baues, et al.. (2022). Role of Baseline Metabolic Tumor Volume in Early-Stage Favorable Hodgkin Lymphoma – Data from the Prospective, Multicenter Phase III HD16 Trial. Nuklearmedizin - NuclearMedicine. 61(2). 150–151. 1 indexed citations

Müller, Horst, Jasmin Mettler, Felicitas Hitz, et al.. (2022). Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma – Data from the prospective, multicenter phase III HD16 trial. BMC Cancer. 22(1). 672–672. 20 indexed citations

Müller, Horst, Jasmin Mettler, Felicitas Hitz, et al.. (2022). P024: Predictive Value of Baseline Metabolic Tumor Volume in Early-Stage Favorable Hodgkin Lymphoma – Data from the Prospective, Multicenter Phase III HD16 Trial. HemaSphere. 6. 12–12. 1 indexed citations

Voltin, Conrad‐Amadeus, Simone Wegen, Thomas Fischer, et al.. (2022). Dual-tracer PET/CT protocol with [¹⁸F]-FDG and [⁶⁸Ga]Ga-FAPI-46 for cancer imaging - a proof of concept.. Journal of Nuclear Medicine. 63(11). jnumed.122.263835–jnumed.122.263835. 15 indexed citations

10.

Kutsch, Nadine, Philipp Gödel, Conrad‐Amadeus Voltin, et al.. (2022). Sustained Remission of Relapsed Diffuse Large B-cell Lymphoma After Safe Administration of CD19-directed CAR T-cells in a Patient With Chronic Intestinal and Pulmonal GvHD. HemaSphere. 6(7). e735–e735. 1 indexed citations

11.

Voltin, Conrad‐Amadeus, Stefanie Kreissl, Jasmin Mettler, et al.. (2022). P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma. HemaSphere. 6. 4–4. 1 indexed citations

12.

Baues, Christian, Helen Goergen, Michael Fuchs, et al.. (2021). Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial. International Journal of Radiation Oncology*Biology*Physics. 111(4). 900–906. 6 indexed citations

13.

Voltin, Conrad‐Amadeus, Jasmin Mettler, Jirka Grosse, et al.. (2020). FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview. Cancers. 12(3). 601–601. 27 indexed citations

14.

Voltin, Conrad‐Amadeus, Jasmin Mettler, Helen Goergen, et al.. (2020). Early Response to First-Line Anti–PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial. Clinical Cancer Research. 27(2). 402–407. 30 indexed citations

15.

Voltin, Conrad‐Amadeus, Jasmin Mettler, Horst Mueller, et al.. (2019). Metabolic Tumor Volume for Early Response Assessment in Early-Stage Unfavorable Hodgkin Lymphoma Treated with Nivolumab in the GHSG Nivahl Phase II Trial. Blood. 134(Supplement_1). 4020–4020. 3 indexed citations

16.

Voltin, Conrad‐Amadeus, Helen Goergen, Christian Baues, et al.. (2018). Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18. Annals of Oncology. 29(9). 1926–1931. 33 indexed citations

17.

Mettler, Jasmin, Horst Müller, Conrad‐Amadeus Voltin, et al.. (2018). Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma. Journal of Nuclear Medicine. 60(2). 207–211. 59 indexed citations

18.

Voltin, Conrad‐Amadeus, Jasmin Mettler, Ronald Boellaard, et al.. (2018). Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma. Nuclear Medicine Communications. 40(3). 249–257. 6 indexed citations

19.

Kobe, Carsten, Helen Goergen, Christian Baues, et al.. (2018). Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma. Blood. 132(21). 2273–2279. 25 indexed citations

20.

Kobe, Carsten, Conrad‐Amadeus Voltin, Christian Baues, et al.. (2017). Staging Hodgkin Lymphoma Using PET - Can We Safely Exclude Bone Marrow Involvement?. Kölner Universitäts PublikationsServer (Universität zu Köln).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact